Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.
about
Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerAssessment, origin, and implementation of breath volatile cancer markers.Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitroProduct ion distributions for the reactions of NO(+) with some physiologically significant volatile organosulfur and organoselenium compounds obtained using a selective reagent ionization time-of-flight mass spectrometer.Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro.Investigation of VOCs associated with different characteristics of breast cancer cellsA Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.A non-invasive tool for detecting cervical cancer odor by trained scent dogsAssessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical propertiesVolatile metabolomic signature of human breast cancer cell lines.Nanoscale Sensor Technologies for Disease Detection via Volatolomics.Determination of volatile organic compounds exhaled by cell lines derived from hematological malignancies.Breath testing as a method for detecting lung cancer.Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis.Volatile Organic Compounds in the Breath of Oral Squamous Cell Carcinoma Patients: A Pilot Study.Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
P2860
Q26796389-1303AB26-57BE-4B56-87B2-4B97D153EE50Q27692565-940088A2-328E-4EA4-A8C4-9033AA169A09Q28601030-E134EB9B-BBAA-4984-89BC-B204DDC04A00Q34079351-4E6391C7-004E-444E-9F5D-8A0685DE4FEFQ34900602-EF3CFDF9-48E2-4468-8558-D0D43D0B7A11Q35992807-4ACB04EA-4A2F-453A-9B1A-37DE18396EE8Q36012613-A0B9E798-0910-455F-A614-2E1B7DDC84AFQ36260194-C39417DC-D78A-4A21-996D-E45E83FA9E4EQ37138493-AEFC35DB-5AF7-4745-A685-2D9C8128DB05Q37678902-A52746AA-DA7A-4512-9BFE-681F2F1BAE4BQ38602462-600B9622-50EC-46E2-B423-87CB0BFD8337Q38703407-2CCD088F-AFF0-47A3-A9CF-0FDA38259F76Q46425527-49BA4066-9001-4CB5-BF11-80838F345683Q47278835-765A97C6-C4F3-41D5-9F8B-FC315C955AD4Q47354446-2D3C2DFB-75F6-4F7A-B0EB-39CA6199844BQ48791026-0FC707F7-15B9-41C0-9DDB-484ABBEC113BQ55070678-AF63BB2B-BA04-4938-B537-069FA59417BE
P2860
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@ast
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@en
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells
@nl
type
label
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@ast
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@en
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells
@nl
prefLabel
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@ast
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@en
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells
@nl
P2093
P2860
P921
P356
P1476
Release and uptake of volatile ...... cinoma cells (HepG2) in vitro.
@en
P2093
Andreas Sponring
Anton Amann
Jakob Troppmair
Julian King
P2860
P2888
P356
10.1186/1475-2867-13-72
P577
2013-07-17T00:00:00Z
P5875
P6179
1013945654